Announcement of FREE PUBLISHED

                                Call for Papers
                        Trends in Immunotherapy
 
Editor-in-Chief
Prof. Dr. Fukumi Furukawa
President
Takatsuki Red Cross Hospital, Japan
E-mail: ffurukawa@takatsuki.jrc.or.jp
 
Associate Editors
Prof. Hiroki Yamaue
Wakayama Medical University
Japan
Prof. Toshikazu Kondo
Wakayama Medical University
Japan
 
Indexing
Trends in Immunotherapy has been indexed in such database as: Scopus,
Google Scholar, Crossref, CNKI Scholar, Worldcat. Trends in Immunotherapy
aims to be indexed by PubMed, ProQuest, MEDLINE and Science
Citation Index (SCI).
 
Key themes for submissions
Key themes for submissions include but are not limited to:
  1. Cancer immunotherapy
  2. Immunomodulators
  3. Antibodies
  4. Allergy disorder and immunotherapy
  5. Therapeutic method for auto-immune disorder
  6. Immunotherapy cell-products
  7. Cytokines application
  8. Immuno-modulatory effects of natural products
Preliminary studies, pre-clinical and clinical investigative reports are welcomed.
The journal accepts original research article, review article, case reports and
short communications.
 
Submission Information
Submission deadline: 30 November 2021 for Volume 5, 2021
 
The papers will be FREE PUBLISHED under such circumstances:
1. The field of manuscripts meets the requirements of the journal;
2. As part of the standard procedure, the manuscripts will be sent to two
members of its Board of Reviewing Editors, who recommended that it go out
for peer review and pass the review.
3. The papers submitted from August 26, 2021 to August 25, 2022.
The above three conditions are met at the same time, we will publish free.
 
All submissions must be made via Online Submissions.
Please refer to the author guidelines before submitting. If you have any further
queries, please contact the Guest Editors.
 
Why US
Trends in Immunotherapy is an open access, peer-reviewed journal
encompassing various disciplines related to the immune-based therapeutic
method. It was founded in 2017. After several years of hard work, the journal
TI was accepted by Scopus in July 2021 under the leadership of the
editor-in-chief and the cooperation of the editorial committee. EnPress
Publisher LLC is an inclusive, progressive and professional publisher. Give us
a chance to cooperate with each other. We will serve you well!








contact us

14701 Myford Road, Suite B-1, Tustin, CA 92780, United States
Tel:+1 (949) 299 0192